Yabao Pharmaceutical Group Co., Ltd
SHH: 600351.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Wei Ren
- Employees
- 4,142
- Headquarters
- Yuncheng, China
- IPO year
- 2002
- Market cap
- CN¥4.9B
- Website
- https://www.yabao.com.cn
Loading 600351…
Loading profile data…Frequently asked questions about 600351
What does Yabao Pharmaceutical Group Co., Ltd (600351.SS) do?
Yabao Pharmaceutical Group Co., Ltd researches, develops, manufactures, and sells Chinese and Western medicines, APIs, and pharmaceutical packaging materials in China and internationally. The company provides products for pediatrics, female healthcare, cardiovascular, big health, and elderly chronic diseases under the Diarrago, Baiyu, and Yabao...
Where does 600351.SS trade?
Yabao Pharmaceutical Group Co., Ltd (600351.SS) trades on the Shanghai Stock Exchange.
What sector is 600351.SS in?
Yabao Pharmaceutical Group Co., Ltd (600351.SS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Yabao Pharmaceutical Group Co., Ltd?
Wei Ren is the chief executive officer of Yabao Pharmaceutical Group Co., Ltd (600351.SS).
Where is Yabao Pharmaceutical Group Co., Ltd headquartered?
Yabao Pharmaceutical Group Co., Ltd is headquartered in China.
Does 600351.SS pay a dividend?
Yes — Yabao Pharmaceutical Group Co., Ltd (600351.SS) paid a trailing twelve-month dividend of CNY 0.50 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 600351.SS go public?
Yabao Pharmaceutical Group Co., Ltd (600351.SS) completed its initial public offering in 2002.